European Commission Grants Ocugen Orphan Medicinal Product Designation for Gene Therapy Product Candidate, OCU400, For the Treatment of Both Retinitis Pigmentosa and Leber Congenital Amaurosis February 23, 2021February 23, 2021
Monoclonal antibody therapy shows promise among Modesto community clinic COVID-19 patients February 12, 2021February 12, 2021